Protein tyrosine kinases (PTKs) provide a pivotal mechanism of signal transmission in response to extracellular cues that regulate cell proliferation, differentiation and migration. Uncontrolled activation of PTKs is implicated in abnormal proliferation and migration of cancer cells and their deficiencies result in pathological conditions such as developmental abnormalities or immuno-deficiencies. Understanding the biochemical basis of PTK regulation is therefore a major goal in cell and cancer biology. The c-cbl protooncogene product has recently emerged as a negative regulator of PTKs. The applicant has shown that Cb functions as a negative regulator of Src-family tyrosine kinases (SFKs) which are known to play crucial roles in integrin-mediated cell migration. Based on these recent findings, the applicant will investigate the hypothesis that Cbl targets activated SFKs for ubiquitin-dependent degradation, by providing a scaffold for juxtaposition of a Cbl RING finger-bound ubiquitin conjugating enzyme (E2) and SFK-bound ubiquitin ligase (E3). Based on earlier findings on SFKs, and initial evidence using Cbl-/-cells, the applicant also hypothesizes that Cbl-dependent degradation of SFKs promotes focal adhesion disassembly, a process essential for directional cell migration. Here Dr. Band will test these hypotheses in the context of a well-characterized SFK, Fyn. The applicant will use Cbl-/-, Cbl-reconstituted and wildtype primary embryonic fibroblast (PEF) cells, and cells that are temperature-sensitive for ubiquitination, to demonstrate the role of Cbl in ubiquitination and degradation of SFKs. The applicants will use mutagenesis to define Cbl and Fyn domains required for their interactions with E2 and E3, respectively. The applicant will then use the mutants to reconstitute Cbl-/- or SFK-/- cells to define the requirement of Cbl in SFK-mediated cell migration. Together with analyses of the nature of focal adhesion signaling in reconstituted cells, these analyses aim to establish a novel paradigm of tyrosine kinase regulation and control of directed cell migration, a fundamental cell biological process. The insights gained through these studies are likely to be a significant relevance to a variety of conditions where tyrosine kinases are implicated, including immune deficiencies, autoimmunity and cancer. Given the role of cell migration in invasion and metastasis, the transforming ability of Src-family kinases when relieved of their negative regulatory mechanisms, and the oncogenic potential of Cbl, these studies are particularly relevant to cancer. These studies may also elucidate aspects of pathogenesis in Angelman's syndrome, caused by mutations in E6AP gene.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA087986-05
Application #
6797616
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Perry, Mary Ellen
Project Start
2000-07-01
Project End
2005-06-30
Budget Start
2003-09-01
Budget End
2004-06-30
Support Year
5
Fiscal Year
2003
Total Cost
$273,600
Indirect Cost
Name
Northshore University Healthsystem
Department
Type
DUNS #
069490621
City
Evanston
State
IL
Country
United States
Zip Code
60201
Luan, Haitao; Mohapatra, Bhopal; Bielecki, Timothy A et al. (2018) Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program. Cancer Res 78:2524-2535
Iseka, Fany M; Goetz, Benjamin T; Mushtaq, Insha et al. (2018) Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. J Immunol 200:483-499
Mohapatra, Bhopal; Zutshi, Neha; An, Wei et al. (2017) An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance. Development 144:1072-1086
Lv, Kaosheng; Jiang, Jing; Donaghy, Ryan et al. (2017) CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies. Genes Dev 31:1007-1023
Olou, Appolinaire A; Sarkar, Aniruddha; Bele, Aditya et al. (2017) Mammalian ECD Protein Is a Novel Negative Regulator of the PERK Arm of the Unfolded Protein Response. Mol Cell Biol 37:
Nadeau, Scott A; An, Wei; Mohapatra, Bhopal C et al. (2017) Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene. J Biol Chem 292:3666-3682
Shukla, Ashima; Rai, Karan; Shukla, Vipul et al. (2016) Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL. Blood 127:2310-21
Bhagirath, Divya; Zhao, Xiangshan; Mirza, Sameer et al. (2016) Mutant PIK3CA Induces EMT in a Cell Type Specific Manner. PLoS One 11:e0167064
Cypher, Luke R; Bielecki, Timothy Alan; Adepegba, Oluwadamilola et al. (2016) CSF-1 receptor signalling is governed by pre-requisite EHD1 mediated receptor display on the macrophage cell surface. Cell Signal 28:1325-35
Bhattacharyya, Sohinee; Rainey, Mark A; Arya, Priyanka et al. (2016) Endocytic recycling protein EHD1 regulates primary cilia morphogenesis and SHH signaling during neural tube development. Sci Rep 6:20727

Showing the most recent 10 out of 107 publications